Yüklüyor......
A perspective on B-cell-targeting therapy for SLE
In recent years, large controlled trials have tested several new agents for systemic lupus erythematosus (SLE). Unfortunately, none of these trials has met its primary outcome. This does not mean progress has not been made. In fact, a great deal has been learned about doing clinical trials in lupus...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3927150/ https://ncbi.nlm.nih.gov/pubmed/19669389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10165-009-0213-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|